GEMAYEL GEORGES Insider Trades

Insider Trading History

Track insider trading activity for GEMAYEL GEORGES. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Disc Medicine
Disc Medicine IRON
Director
Holding Value $466k 6,212 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$440k 6,212 shares
$70.79
$75.01
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $1.3M 27,277 shares
Last Trade
Mar 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$466k 8,787 shares
$53.00
$47.73
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Mar 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$426k 7,905 shares
$53.87
$47.73
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $1.72M 36,064 shares
Last Trade
Mar 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$426k 7,905 shares
$53.87
$47.73
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $1.34M 28,159 shares
Last Trade
Mar 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$537k 10,000 shares
$53.71
$47.73
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Feb 24, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$239k 4,475 shares
$53.30
$47.73
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $1.82M 38,159 shares
Last Trade
Feb 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239k 4,475 shares
$53.30
$47.73
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $1.61M 33,684 shares
Last Trade
Feb 23, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$760k 15,000 shares
$50.69
$47.73
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Feb 23, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$760k 15,000 shares
$50.69
$47.73
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $143k 2,989 shares
Last Trade
Feb 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 2,989 shares
$50.20
$47.73
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $238k 4,977 shares
Last Trade
Feb 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 4,977 shares
$50.20
$47.73
Disc Medicine
Disc Medicine IRON
Director
Holding Value $75k 1,000 shares
Last Trade
Sep 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60.3k 1,000 shares
$60.34
$75.01
Disc Medicine
Disc Medicine IRON
Director
Holding Value $750k 10,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$509k 10,000 shares
$50.86
$75.01
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Feb 22, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$177k 5,369 shares
$33.05
$47.73
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $892k 18,684 shares
Last Trade
Feb 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$177k 5,369 shares
$33.05
$47.73
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $348k 7,296 shares
Last Trade
Feb 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$245k 7,296 shares
$33.52
$47.73
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $1.15M 24,102 shares
Last Trade
Nov 08, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$395k 10,787 shares
$36.60
$47.73
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $636k 13,315 shares
Last Trade
Nov 08, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$392k 10,787 shares
$36.30
$47.73
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Nov 08, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$395k 10,787 shares
$36.60
$47.73
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $1.31M 27,528 shares
Last Trade
Nov 07, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$517k 14,213 shares
$36.40
$47.73

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up